Larimar Therapeutics, Inc. (LRMR) - Latest Market Data

Price & Market Data

Price: $4.79

Daily Change: $0.00 / 0.00%

Daily Range: $4.20 - $4.82

Market Cap: $497,599,264

Daily Volume: 1,840,806

Performance Metrics

1 Week: -1.24%

1 Month: -12.11%

3 Months: 25.72%

6 Months: 15.42%

1 Year: 117.7%

YTD: 25.72%

Company Details

Employees: 71

Sector: Health technology

Industry: Biotechnology

Country: United States

Details

Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 2 OLE clinical trial for the treatment of Friedreich's ataxia, a rare, progressive and fatal genetic disease. The company is based in Bala Cynwyd, Pennsylvania.

Selected stocks

Xerox Holdings Corporation (XRX)

Bio Green Med Solution, Inc. (BGMS)

The Marygold Companies, Inc. (MGLD)